Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Rhythm Pharmaceuticals Announces First Patient Dosed In Phase 1 Trial Evaluating RM-718

Author: Benzinga Newsdesk | March 25, 2024 08:04am

- Three-part study to evaluate safety, tolerability and pharmacokinetics now underway --

-- RM-718 showed potential to reduce body weight and hyperphagia, no hyperpigmentation

observed in preclinical studies --

Posted In: RYTM